| Amiodarone HCl (Test 2) |
Tablet |
I (Basket) |
50 |
Acetate Buffer, pH 4.0, with 1% Tween 80 |
900 |
10, 20, 30, 45, 60 and 90 |
2004/01/12 |
| Amitriptyline HCl |
Tablet |
|
|
Refer to USP |
|
|
2008/01/14 |
| Amlodipine Besylate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Amlodipine Besylate |
Tablet (Orally Disintegrating) |
II (Paddle) |
50 |
0.01 N HCl |
500 |
5, 10, 15 and 20 |
2008/10/06 |
| Amlodipine Besylate/Atorvastatin Calcium |
Tablet |
II (Paddle) |
75 |
Phosphate Buffer, pH 6.8 |
900 |
5, 10, 15 and 30 |
2009/04/02 |
| Amlodipine Besylate/Benazepril HCl |
Capsule |
I (Basket) |
100 |
0.01 N HCl |
500 |
10, 20 , 30, 45, and 60 |
2007/06/20 |
| Amlodipine Besylate/Hydrochlorothiazide/Olmesartan Medoxomil |
Tablet |
II (Paddle) |
50 |
Phosphate Buffer, pH 6.8 |
900 |
5, 10, 15, 20, 30 and 45 |
2011/07/21 |
| Amlodipine Besylate/Hydrochlorothiazide/Valsartan |
Tablet |
|
|
Refer to USP |
|
|
2016/07/28 |
| Amlodipine Besylate/Olmesartan Medoxomil |
Tablet |
II (Paddle) |
50 |
Phosphate Buffer, pH 6.8 |
900 |
10, 20, 30 and 45 |
2008/08/11 |
| Amlodipine besylate/Perindopril Arginine |
Tablet |
II (Teflon coated paddle) |
75 |
0.01 N HCL |
1000 |
5, 10, 15, 20 and 30 |
2016/03/17 |
| Amlodipine Besylate/Telmisartan |
Tablet |
II (Paddle) |
75 |
Telmisartan: Phosphate Buffer, pH 7.5; Amlodipine: 0.01N HCl, pH 2 |
Telmisartan: 900; Amlodipine: 500 |
Telmisartan: 10, 15, 20, 30 and 45; Amlodipine: 10, 15, 20, 30 and 45 |
2010/08/05 |
| Amlodipine Besylate/Valsartan |
Tablet |
|
|
Refer to USP |
|
|
2016/07/28 |
| Amoxicillin |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Amoxicillin |
Capsule |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Amoxicillin |
For Oral Suspension |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Amoxicillin |
Tablet (Extended Release) |
II (Paddle) |
100 |
3 Stage dissolution: 50 mM potassium phosphate monobasic buffer at pH 4.0 (0-2 hours), 6.0 (2-4 hours) and 6.8 ( 4 hours and beyond) |
900 |
0.25, 0.5, 1, 2, 2.25, 2.5, 3, 4, 4.25, 4.5, 5 and 6 hours |
2010/10/21 |
| Amoxicillin/Clarithromycin/Lansoprazole |
Capsule/Tablet/Capsule (Copackage) |
|
|
Develop a dissolution method for Amoxicillin Capsules, Refer to USP for monographs of Clarithromycin Tablets and Lansoprazole Delayed-Release Capsules |
|
|
2024/01/03 |
| Amoxicillin/Clarithromycin/Omeprazole |
Capsule/Tablet/Capsule (Copackage) |
|
|
Develop a dissolution method for Amoxicillin Capsules, Refer to USP for monographs of Clarithromycin Tablets and Omeprazole Delayed-Release Capsules |
|
|
2024/01/03 |
| Amoxicillin/Clavulanate Potassium |
Tablet |
|
|
Develop a dissolution method |
|
|
2024/01/03 |
| Amoxicillin/Clavulanate Potassium |
Suspension |
|
|
Develop a dissolution method |
|
|
2023/09/15 |